Preeclampsia (PE), a pregnancy-specific disorder, is a leading cause of perinatal maternal-fetal mortality and morbidity. Impaired cell migration and invasion of trophoblastic cells and an imbalanced systemic maternal inflammatory response have been proposed as potential mechanisms of PE pathogenesis. Comparative analysis between PE placentas and normal placentas profiled differentially expressed miRNAs, lncRNAs, and mRNAs, including miR-19a-3p (miRNA), PSG10P (lncRNA), and IL1RAP (mRNA). This study was conducted to investigate their potential roles in PE pathogenesis. The expression of miR-19a-3p, PSG10P, and IL1RAP was examined in PE and normal placentas using RT-qPCR. An in vitro experiment was performed in human trophoblast HET8/SVneo and TEV-1 cells cultured in normoxic and hypoxic conditions. MiR-19a-3p targets were identified using Targetscan, miRanda, and PicTar analysis as well as luciferase reporter assays. The mouse model of PE was conducted using sFlt-1 for in vivo tests. Lower levels of miR-19a-3p, but higher levels of PSG10P and IL1RAP were observed in PE placentas and the trophoblast cells in hypoxia. Luciferase reporter assays confirmed that PSG10P and IL1RAP were both direct targets of miR-19a-3p. Exposure to hypoxia inhibited cell viability, migration, and invasion of HET8/SVneo and TEV-1 cells. Knocking out PSG10P and IL1RAP or overexpressing miR-19a-3p rescued the inhibition caused by hypoxia. In vivo experiments showed that IL1RAP promoted the expression of caspase-3, a key apoptosis enzyme, but inhibited MMP9, which is responsible for degrading the extracellular matrix, suggesting a significant role of IL1RAP in cell proliferation, migration, and invasion. miR-19a-3p, PSG10P, and IL1RAP were all found to be involved in PE pathogenesis. With a common targeting region in their sequences, a regulatory network in the PSG10P/miR-19a-3p/IL1RAP pathway may contribute to PE pathogenesis during pregnancy.
| INTRODUCTION
Preeclampsia (PE) is a pregnancy-specific disease characterized by hypertension (defined as systolic blood pressure P140 mm Hg or diastolic blood pressure P90 mm Hg) and proteinuria (>300 mg protein in a 24-hour urine specimen and/or protein to creatinine ratio of >0.30) that occurs after 20 weeks of pregnancy.
1,2 PE affects 3%-8% of pregnancies worldwide and triggers problems in the liver, kidney, brain, and the clotting system during pregnancy. 3 As a result, PE is still one of the leading causes of maternal and fetal morbidity and mortality. 4 Growing evidence supports that PE results from abnormal placental development and function, 3, 4 however, the pathophysiological mechanisms of PE remain poorly understood. In normal pregnancies, cytotrophoblasts (CTBs) migrate through the decidua and myometrium in order to invade the maternal spiral arteries of the endothelium and tunica media. 5 Inadequate invasion possibly results in reduced uteroplacental perfusion pressure (RUPP) and placental ischaemia/hypoxia. 6 Ischaemia-induced oxidative stress also leads to the apoptosis and necrosis of the placenta as well as the release of several placental factors, resulting in endothelial dysfunction, and systemic inflammation. 7 In normal pregnancies, placentas promote maternal tolerance to fetal antigens partly through producing immunosuppressive molecules, inhibiting chemokine expression and complement activation, entrapping professional antigen-presenting cells, and excluding immune cells. [8] [9] [10] However, in patients with PE, abnormal placentation is associated with an exaggerated systemic maternal inflammatory response, which contributes to adverse pregnancy outcomes. [8] [9] [10] Upon deciphering the human genome, large-scale investigations of non-coding RNAs (ncRNAs), including miRNAs and lncRNAs, have been conducted in many fields. MicroRNAs (miRNAs) are small (18- 24 nt) endogenous non-coding single-stranded RNAs. MiRNAs regulate mRNA, which encode proteins that modulate cellular functions, by binding to the untranslated region (3′UTR) of target mRNAs. As a result, target gene expression can be regulated post-transcriptionally through degradation of target mRNAs. 11 Therefore, miRNAs play important roles in physiological homoeostasis in health and pathophysiological dysregulation in disease. 11, 12 To date, more than 1000 miRNAs have been validated in humans, among which more than 600 miRNAs are expressed in the human placenta. 13 Abnormal expression of specific miRNAs has been reported in various studies of human diseases, including PE. 11 Comparative analysis between PE placentas and normal placentas identified 11 up-regulated and 23
down-regulated miRNAs. 14 Among them, Has-miR-19a was downregulated by 0.488-fold. Transcriptional downregulation of miR-19a was also observed under oxidative stress. 15 Overexpression of miR19a protects endothelial cells from lipopolysaccharide-induced apoptosis 16 and enhanced cell invasion and metastasis. 17 These findings imply a putative implication of miR-19a in the physiological pathological mechanisms of PE.
LncRNAs (long non-coding RNAs) are non-coding RNAs that are longer than 200 nt in length. LncRNAs can regulate gene expression potentially through complementary binding or as coregulators. 18 Dysregulation of lncRNAs has been associated with many human diseases. 18 To better understand the expression of lncRNAs and their biological functions in PE, an expression profile of lncRNAs of PE placenta was sequenced by He et al. 19 In the GSE50783 dataset, lncRNA-PSG10P was significantly up-regulated in PE placentas compared to normal placentas. 19 Pregnancy-specific glycoproteins (PSGs) are the most abundant trophoblastic proteins in maternal blood during pregnancy. 20 PSG10P is a noncoding pseudogene.
Additionally, significant overexpression of IL-1 receptor accessory protein (IL1RAP) mRNA was also detected in the GSE50783 dataset. N: normal controls; P: pre-eclampsia patients.
3 days for both conditions. Cell viabilities were examined at 0, 12, 24, and 48 hours using a cell counting kit-8 (CCK-8, Dojindo Laboratories, Mashiki-machi, Japan). The relative cell viability was calculated by comparing cell number at later time points (12, 24, and 48 hours) to that at the starting point (0 hour). | 855 culture medium was used in the subsequent cell culture. At 48 hours after scratching, microscopic images of the same area were captured.
| Cell transfection
Cell migration was calculated based on the distance between the initial and final positions.
| RNA pull-down assay
An RNA pull-down assay was performed to selectively extract the RNA(PSG10P)-RNA (miR-19a-3p) complex at 48 hours from transfected samples. Biotinylated RNA probes (Bio-miR-NC, Bio-miR19a-3p and Bio-miR-19a-3p-Mut) were incubated with the cell lysates and purified using streptavidin-coupled magnetic beads according to the instructions of the Pierce Magnetic RNA PullDown Kit (Rockford, IL, USA). RNA-RNA complexes were then eluted using the salt solution and purified using TRIzol (Pierce).
The enrichment of PSG10P was quantified using qPCR as described above.
| Animal treatment
The animal experiment was approved by the Ethical Committee for mice were randomly selected for mmu-miR-agomir treatment as negative controls (PE+NC), 12 for mmu-miR-19a-3p agomir treatment (PE+Agomir), and 12 as PE controls (PE). The mmu-miR-19a-3p agomir (GenePharma) was used to increase miR-19a-3p expression in PE mice. Both mmu-miR-agomir and mmu-miR-19a-3p agomir were injected into mice tail veins on day 13 of gestation at a rate of 100 μL/day for 6 days. In addition, another 12 normal pregnant mice were treated with saline solution as controls (Nor).
| Data and tissues collection
Non-invasive tail-cuff blood pressure (BP) was measured in conscious mice using a non-invasive automated sphygmomanometer (BP-98A, Softron, Beijing, China). Mice were incubated at 38°C for 15 minutes to stabilize their physical signs and to expand their local vessels sufficiently. The pressurized sensor was placed in their tail, then blood pressure was measured after mice had calmed down for a few sec- 
| Immunohistochemical staining
The placenta tissues were embedded in paraffin and sectioned into 
| Statistical analysis
Data were analysed using SPSS 12.0 software (SPSS, Inc., Chicago, IL, USA). One-way analysis of variance followed by Scheffe's posthoc test was performed to evaluate statistical significance (P < 0.05).
3 | RESULTS 3.1 | Significantly higher PSG10P and IL1RAP levels but lower miR-19a-3P levels are present in PE placentas compared to levels in normal placentas GSE50783 datasets revealed a significantly higher expression level of PSG10 in PE placentas than in normal placentas (P < 0.05, Figure 1A1 ), 19 which was also identified in the present study using more tissue samples (P < 0.01, Figure 1A2 ), but PSG10 was not detectable in the serum from either patients with PE or healthy controls (data not shown). miR-19a-3p, which was previously reported to be down-regulated in PE placentas, 14 was predicted to bind PSG10. The present study not only identified the downregulation of miR-19a-3p in PE placentas (P < 0.01, Figure 1B1 ), but also found a dramatic reduction in the serum of patients with PE (P < 0.01, Figure 1B2 ). From GSE50783 datasets, we found that five up-regulated mRNAs (INHBA, IL1RAP, TREM1, PSG11, and RASEF) in PE placentas were targeted by miR-19a-3p. However, our PCR measurement only showed the up-regulation of INHBA (P < 0.01) and IL1RAP (P < 0.001, Figure 1C) , with the greatest increase in IL1RAP. Figure 1D1 shows the expression profile of IL1RAP in GSE50783 datasets. IL1RAP protein level was further assessed using western blotting. In agreement with the mRNA expression analysis, IL1RAP protein levels were increased in the PE placentas compared to that in normal placentas (P < 0.01, Figure 1D2 ).
F I G U R E 1 Expression profiles of PSG10P, miR-19a-3p
, and IL1RAP in placentas of patients with pre-eclampsia (PE) and controls and their association with mean arterial pressure (MAP). Expression profiles of PSG10P (A1) and IL1RAP (D1) in GSE50783 datasets were analysed. RT-PCR was performed to detect the expression of PSG10P (A2), miR-19a-3p (B1), and a series of mRNAs (C) in placentas of patients with PE and controls. miR-19a-3p expression was also detected in the serum samples using RT-PCR (B2). Western blotting was performed to detect the expression of IL1RAP in placentas of patients with PE and controls (D2). Association of the relationship between MAP and relative RNA expression of PSG10P, miR-19a-3p, and IL1RAP was analysed by Pearson correlation analysis in patient with PE (F) and normal controls (E). Nor and N:Normal group; Pre and P: Pre-eclampsia group; MAP: Mean arterial pressure. *P < 0.05, **P < 0.01, ***P < 0.001 vs Control were evaluated in this study. MAP showed a significant correlation with all three genes/proteins (all P < 0.05) in patients with PE (Figure 1F ), but the correlation in healthy controls was poor ( Figure 1E ). 
| Alterations of PSG10P, miR-19a-3P, and IL1RAP expression in trophoblast cells after transfection
HTR-8/SVneo and TEV-1 cells were transfected with shRNA-PSG10P, miR-19a-3p mimics, and shRNA-IL1RAP to alter their expression. Transfection rates were more than 80% as indicated by the light microscopy and fluorescent images ( Figure 3A , B, and C).
RT-qPCR analysis showed that transfection with shRNA-PSG10P reduced PSG10P expression in both HTR-8/SVneo and TEV-1 cells compared to that in the negative control (both P < 0.01, Figure 3A ).
However, no change in the expression level was observed upon scramble treatment, confirming the successful knockout of PSG10P.
Transfection with miR-19a-3p mimics increased miR-19a-3p expression in HTR-8/SVneo (P < 0.01) and TEV-1 cells (P < 0.001) compared to the negative control. shRNA-IL1RAP transfection decreased IL1RAP expression in HTR-8/SVneo and TEV-1 cells (both P < 0.01).
| PSG10P and miR-19a-3p expression are negatively correlated in trophoblast cells
PSG10P knockout was associated with a remarkable increase in miR19a-3p expression in both HTR-8/SVneo and TEV-1 cells (both P < 0.05, Figure 4A ). Transfection with miR-19a-3p mimics conversely decreased PSG10P expression in HTR-8/SVneo (P < 0.05, Figure 4B ) and TEV-1 cells (P < 0.01).
The bioinformatic tools (Targetscan, miRanda, and PicTar) predicted that PSG10P is a direct target of miR-19a-3p and showed a putative complementary region. In luciferase reporter assays, both wild-type and mutant-type of PSG10P constructs showed increased luciferase activity compared to that of the negative control (P < 0.001, Figure 4C ). However, transfection with miR-19a-3p mimics significantly reduced the luciferase activity of the wild-type of PSG10P constructs (P < 0.01), but not that of the mutant type of PSG10P constructs, which confirmed the prediction of the target region. In addition, the interaction between miR-19a-3p and PSG10P
was also identified by RNA pull-down assay: significantly elevated In a luciferase reporter assay, transfection with miR-19a-3p mimics significantly reduced the luciferase activity of the wild-type of PSG10P constructs, but not that of the mutant PSG10P constructs (C). RNA pulldown analysis indicated that PSG10P interacted with WT-hsa-miR-19a-3p, but not with MT-hsa-miR-19a-3p (D). *P < 0.05, **P < 0.01, and ***P < 0.001 relative PSG10P enrichment was only observed in wild-type miR19a-3p, but not in the mutant ( Figure 4D ).
| IL1RAP is a direct target of miR-19a-3p
The mimics of miR-19a-3p significantly increased its relative RNA expression, while the inhibitors significantly inhibited its expression ( Figure 5A ). However, opposite expression behaviours were detected for IL1RAP; significantly lower relative RNA expression of IL1RAP was observed upon miR-19a-3p mimics treatment, but higher expression was observed in inhibitor treatment ( Figure 5B ). The putative binding site of miR-19a-3p in the 3′-UTR region of IL1RAP is shown in Figure 5C . The transfection with miR-19a-3p mimics significantly reduced the luciferase activity of the wild-type of IL1RAP 3′UTR constructs (P < 0.01, Figure 5D ), but not that of the mutant-type. they all significantly promoted cell migration and cell invasion under hypoxia (vs hypoxic group, P < 0.01).
| Increased miR-19a-3p expression rescued PE symptoms in vivo
The mouse model of PE was established using sFlt-1. From day 13, MAP significantly increased and reached as high as 140 at day 18 in the PE pregnant mice (P < 0.01, Figure 7D ), urinary protein concentrations in the PE pregnant mice were dramatically increased (P < 0.05, Figure 7E ), and PE pregnant mice showed reduced fetal survival number (P < 0.05, Figure 7F ). miR-19a-3p expression was decreased in the placenta of PE pregnant mice (P < 0.05, Figure 7A ).
Injection of mmu-miR-19a-3p reversed the miR-19a-3p expression (vs PE group, P < 0.05, Figure 7A ), but injection of mmu-miR-NC had no such effect. PE pregnant mice showed increased IL1RAP and activated caspase-3 levels (P < 0.05 and P < 0.01, respectively, Figure 7B ), but decreased MMP-9 (P < 0.01, Figure 7B ) and Ki-67 (Figure 7C ) levels in the placenta. The injection of mmu-miR-19a-3p, but not mmu-miR-agomir, decreased protein levels of IL1RAP, and activated caspase-3 (vs PE group, P < 0.01 and P < 0.05, respectively), but increased the MMP-9 level (vs PE group, P < 0.01) and Ki-67 in the PE pregnant mice. Importantly, the injection of mmu-miR-19a-3p recovered urinary protein concentration (vs PE group, P < 0.01, Fig- ure 7E) and MAP (vs PE group, P < 0.05, Figure 7D ), as well as improved fetal survival number (vs PE group, P < 0.05, Figure 7E ) in the PE pregnant mice. In the luciferase reporter assay, transfection with miR-19a-3p mimics significantly reduced the luciferase activity of the wild-type of IL1RAP constructs, but not that of the mutant IL1RAP constructs (B). **P < 0.01 known that sFlt-1 can cause vascular endothelial dysfunction and further induce many abnormal symptoms commonly observed in PE, such as oxidative stress, imbalanced inflammatory response, hypotension, and proteinuria. 26, 27 The relationship between PSG10P and miR-19a-3p was and consequent reduction of RUPP. 6 Reduced RUPP has been confirmed as a leading cause for oxidative stress and over-activation of the inflammatory response. 7 Therefore, the improved cell viability and invasion capacity of trophoblast cells became very important to attenuate or prevent the adverse reactions in PE. Decreased expression of miR-19a-3p was observed in the placentas of patients with PE, PE pregnant mice, as well as in trophoblast cells under hypoxia.
| DISCUSSION
The overexpression of miR-19a-3p improved the cell viability, migration, and invasion under hypoxaemia in our in vitro study. Moreover, 
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